Dihexa is a small, man-made compound based on a fragment of angiotensin IV, a natural peptide found in the brain. In rat and mouse studies it was linked to new connections forming between nerve cells and to better scores on memory tests. But it has not been tested in completed human trials, one of its key mechanism papers has since been retracted, and it is not a medicine. This guide explains what that means in plain English.
Dihexa is searched more than 1,500 times a month in the UK, and most of the pages that come up are selling it or making big promises. We have taken a different approach: we read the original papers, checked their status on PubMed, and summarised the findings honestly, including the parts that sellers tend to leave out. Everything here is about laboratory research. For laboratory research use only.
What is Dihexa, in simple terms?
Dihexa is often called a “peptide”, but strictly speaking it is a modified peptide fragment, sometimes described as a peptidomimetic. Researchers started with angiotensin IV, a six-amino-acid peptide (Val-Tyr-Ile-His-Pro-Phe) that is part of the brain’s renin-angiotensin system. Earlier work suggested that only the first three building blocks carried most of its activity in memory experiments.
The team then changed both ends of that short fragment so enzymes could not break it down so quickly and so it could cross the barrier between the blood and the brain. The result was N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, nicknamed Dihexa (also coded PNB-0408 in some sources). The work was published in 2013 by McCoy and colleagues in the Journal of Pharmacology and Experimental Therapeutics (PubMed 23055539).
Dihexa at a glance
| Property | Detail |
|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6) aminohexanoic amide |
| Molecular formula | C27H44N4O5 |
| Molecular weight | About 504.7 g/mol (PubChem CID 129010512) |
| Parent molecule | Angiotensin IV (a fragment of the angiotensin peptide family) |
| Main research area | Synapse formation and memory in rodent models |
| UK status | Not a licensed medicine; research compound only |
What does the Dihexa research actually show?
The published evidence is small and almost entirely pre-clinical, meaning it comes from cells and animals. Here are the main studies in plain English.
The original 2013 rat study
McCoy and colleagues reported that Dihexa improved performance in a water maze memory test in rats given scopolamine (a drug used to create a temporary memory deficit in experiments) and in aged rats. They also saw more synapse formation in brain cell cultures. It is worth knowing that the journal published an expression of concern about this paper in 2021, which is a formal notice that questions have been raised about some of the data.
The 2014 mechanism paper, now retracted
A follow-up study by Benoist and colleagues proposed that Dihexa works by binding hepatocyte growth factor (HGF) and boosting its receptor, called c-Met, which is involved in growth and repair signalling. This “HGF/c-Met” explanation is the one repeated on most websites. However, the journal issued an expression of concern in 2021 and then retracted the paper in 2025 (PubMed 25187433, marked as retracted). A retracted paper should not be relied on as evidence, so the commonly quoted mechanism is less certain than many pages suggest.
Independent mouse research
A 2021 study from China Pharmaceutical University tested Dihexa in APP/PS1 mice, a strain bred to model features of Alzheimer’s-type memory decline. The authors reported better water maze scores, lower markers of brain inflammation and activation of the PI3K/AKT signalling pathway (Sun et al., 2021, PubMed 34827486). This is useful because it comes from a separate group, but it is still a single animal study.
The wider angiotensin IV picture
A 2018 systematic review of animal studies looked at angiotensin IV and related compounds, including Dihexa, and found that most studies in memory-impaired animals reported improvements on learning tasks (Ho and Nation, 2018, PubMed 29733881). The review only covered non-human experiments, so it tells us about lab models, not people.
Myths vs facts about Dihexa
- Myth: “Dihexa is proven to boost memory.” Fact: improvements have been reported in rats and mice under controlled lab conditions. There are no completed, published human trials showing any effect.
- Myth: “Its mechanism is well established.” Fact: the best-known mechanism paper was retracted in 2025, and the original study carries an expression of concern.
- Myth: “It is millions of times stronger than other compounds.” Fact: this claim comes from lab measurements of synapse formation in cell cultures and does not translate into anything meaningful about people.
- Myth: “It is a licensed medication.” Fact: it has no UK marketing authorisation and is an experimental research compound.
Dihexa vs Semax and Selank: how do they differ?
People researching Dihexa often compare it with other compounds studied in brain and behaviour research. The key differences are in their origin and evidence base:
- Dihexa is a modified angiotensin IV fragment with a small, mostly rodent evidence base and some papers under formal concern.
- Semax is a seven-amino-acid peptide derived from a fragment of ACTH (adrenocorticotropic hormone), with a long research history, mainly from Russian laboratories.
- Selank is a seven-amino-acid peptide based on tuftsin, an immune-related peptide, and is studied in anxiety-related behaviour models.
These are different molecules with different research questions, so results from one cannot be applied to another.
Another compound often mentioned in this group is P21 (P021), a small peptide derived from ciliary neurotrophic factor. Our guide What Is P21 Peptide? explains the mouse research on BDNF and neurogenesis and its limits.
What should a UK lab check before buying research compounds?
Whichever compound you are researching, quality is what makes results trustworthy. Before ordering, check:
- Identity: the certificate of analysis should confirm the molecular weight by mass spectrometry. For Dihexa that would be around 504.7 g/mol.
- Purity: an HPLC trace showing the percentage purity for that exact batch. Our guide on how to read a COA walks through each line.
- Clear research-only labelling and a UK supplier with real contact details and transparent policies.
Every peptide in the Peptides UK research catalogue is HPLC and COA Verified and supplied for laboratory research use only. For a wider view of how to judge suppliers, see our guide to the best research peptides in the UK, and for handling basics read our peptide storage guide.
Is Dihexa regulated in the UK?
Dihexa is not a licensed medicine in the UK. The MHRA regulates medicines, and any product promoted for a medical purpose falls under its rules. Research compounds are supplied for laboratory work, not for human or veterinary use, and labs should follow current official guidance and their own institutional policies.
Dihexa: frequently asked questions
What is Dihexa?
Dihexa is a small synthetic compound built from a modified fragment of angiotensin IV. Its chemical name is N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, and it was designed at Washington State University as a research tool for studying how new connections form between brain cells in animal models.
Is Dihexa a medication?
No. Dihexa is not a licensed medicine in the UK and has no marketing authorisation from the MHRA. It is an experimental research compound, and the published work on it comes from cell and rodent studies rather than completed human clinical trials.
Is Dihexa legal to buy in the UK?
Dihexa is not a licensed medicine, and research compounds like it are sold in the UK for laboratory use only. The legal position for any compound depends on how it is described, supplied and used, so laboratories should check current MHRA guidance and their own institutional rules. This article is not legal advice.
What are the side effects of Dihexa?
There are no published human safety studies for Dihexa, so nobody can honestly list its side effects in people. We do not provide human-use guidance; Dihexa is a laboratory research topic only.
Does Peptides UK sell Dihexa?
Peptides UK does not currently list Dihexa. We cover it here because it is one of the most searched research compounds in the UK, and because readers deserve an honest summary of what the evidence does and does not show.
All Peptides UK products are for laboratory research use only. They are not medicines and are not for human or veterinary use. This article is for educational purposes and is not medical or legal advice.